In this issue:
Atogepant for chronic migraine
Migraine & risks of premature MI/stroke in men/women
Caffeine intake & severe headache/migraine
Concomitant oral preventative treatments & BoNTA
Rimegepant for acute migraine
Zavegepant nasal spray for acute migraine
CGRP monoclonal antibodies & risk of SARS-CoV-2
Diagnostic criteria for menstrual migraine
Varied endpoints in migraine clinical trials
OCTA & microvasculature in migraine
Please login below to download this issue (PDF)